Puciłowski O, Kostowski W, Trzaskowska E
Peptides. 1985 Jan-Feb;6(1):7-10. doi: 10.1016/0196-9781(85)90067-1.
The daily pretreatment of rats with oxytocin (OXY) or MIF-I prior to ethanol (Et-OH) administration markedly altered the alcohol tolerance when tested on the fifth day of treatment. OXY (800 and 2400 nmole/kg SC) and MIF (800 nmole/kg SC) inhibited the development of tolerance to the hypnotic effect of Et-OH. MIF at this dose also inhibited the tolerance to the hypothermic effect. Only OXY in the dose of 800 nmole/kg suppressed hypothermia in an acute experiment with Et-OH and produced by itself hypothermia after acute administration (2400 nmole/kg). The tolerance to this last effect developed after four days of peptide treatment. The results indicate that OXY and MIF-I can influence the processes of development of tolerance to some central depressive effects of Et-OH in rats.
在给大鼠乙醇(Et-OH)之前,每日用催产素(OXY)或MIF-I预处理,在治疗的第五天进行测试时,显著改变了酒精耐受性。OXY(800和2400纳摩尔/千克皮下注射)和MIF(800纳摩尔/千克皮下注射)抑制了对Et-OH催眠作用耐受性的发展。该剂量的MIF也抑制了对体温过低作用的耐受性。在Et-OH急性实验中,只有800纳摩尔/千克剂量的OXY抑制体温过低,并且在急性给药(2400纳摩尔/千克)后自身会产生体温过低。对这最后一种作用的耐受性在肽治疗四天后产生。结果表明,OXY和MIF-I可以影响大鼠对Et-OH某些中枢抑制作用耐受性的发展过程。